Related references
Note: Only part of the references are listed.Human galectin-16 has a pseudo ligand binding site and plays a role in regulating c-Rel-mediated lymphocyte activity
Yunlong Si et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2021)
Human Galectin-1 in Multiple Cancers: A Privileged Molecular Target in Oncology
Nerella Sridhar Goud et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2021)
Inherited Pancreatic Cancer Syndromes and High-Risk Screening
Leah H. Biller et al.
SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA (2021)
Galectin-9 interacts with PD-1 and TIM-3 to regulate T cell death and is a target for cancer immunotherapy
Riyao Yang et al.
NATURE COMMUNICATIONS (2021)
The TIM3/Gal9 signaling pathway: An emerging target for cancer immunotherapy
Sashi Kandel et al.
CANCER LETTERS (2021)
Cancer metabolism: looking forward
Inmaculada Martinez-Reyes et al.
NATURE REVIEWS CANCER (2021)
Lactate modulation of immune responses in inflammatory versus tumour microenvironments
Michelangelo Certo et al.
NATURE REVIEWS IMMUNOLOGY (2021)
Overexpression of the SMYD3 Promotes Proliferation, Migration, and Invasion of Pancreatic Cancer
Cheng-lin Zhu et al.
DIGESTIVE DISEASES AND SCIENCES (2020)
Roles of galectin-3 in metabolic disorders and tumor cell metabolism
Ying-Shuang Li et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2020)
Natural Killer Cells: Diverse Functions in Tumor Immunity and Defects in Pre-neoplastic and Neoplastic Stages of Tumorigenesis
Anahid Jewett et al.
MOLECULAR THERAPY-ONCOLYTICS (2020)
Mechanisms of immune evasion in bladder cancer
Paul L. Crispen et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2020)
Sweetening the hallmarks of cancer: Galectins as multifunctional mediators of tumor progression
Maria Romina Girotti et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2020)
Pancreatic Cancer Associated Fibroblasts (CAF): Under-Explored Target for Pancreatic Cancer Treatment
Jeffrey Norton et al.
CANCERS (2020)
The Galectin Family as Molecular Targets: Hopes for Defeating Pancreatic Cancer
Noemi Manero-Ruperez et al.
CELLS (2020)
Impact of Galectins in Resistance to Anticancer Therapies
Pilar Navarro et al.
CLINICAL CANCER RESEARCH (2020)
Galectin-3 is modulated in pancreatic cancer cells under hypoxia and nutrient deprivation
Antonio F. Silva Filho et al.
BIOLOGICAL CHEMISTRY (2020)
Identification of a novel IL-5 signaling pathway in chronic pancreatitis and crosstalk with pancreatic tumor cells
Sarah B. Gitto et al.
CELL COMMUNICATION AND SIGNALING (2020)
Response and Survival Associated With First-line FOLFIRINOX vs Gemcitabine and nab-Paclitaxel Chemotherapy for Localized Pancreatic Ductal Adenocarcinoma
Giampaolo Perri et al.
JAMA SURGERY (2020)
Galectin-3 Released by Pancreatic Ductal Adenocarcinoma Suppresses γδ T Cell Proliferation but Not Their Cytotoxicity
Daniel Gonnermann et al.
FRONTIERS IN IMMUNOLOGY (2020)
Neuropilin-1 is up-regulated by cancer-associated fibroblast-secreted IL-8 and associated with cell proliferation of gallbladder cancer
Chen Chen et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2020)
Serum galectin-3 as a biomarker for screening, early diagnosis, prognosis and therapeutic effect evaluation of pancreatic cancer
Nan Yi et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2020)
Galectin-8 in the onset of the immune response and inflammation
Maria Tribulatti et al.
GLYCOBIOLOGY (2020)
B lymphocytes contribute to stromal reaction in pancreatic ductal adenocarcinoma
Claudia Minici et al.
ONCOIMMUNOLOGY (2020)
Angiogenesis in pancreatic cancer: current research status and clinical implications
Shuo Li et al.
ANGIOGENESIS (2019)
Inflammation and Pancreatic Cancer: Focus on Metabolism, Cytokines, and Immunity
Andrea Padoan et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
High glucose promotes pancreatic cancer cells to escape from immune surveillance via AMPK-Bmi1-GATA2-MICA/B pathway
Qingke Duan et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Defective Localization With Impaired Tumor Cytotoxicity Contributes to the Immune Escape of NK Cells in Pancreatic Cancer Patients
Seon Ah Lim et al.
FRONTIERS IN IMMUNOLOGY (2019)
IL-4 and IL-17A Cooperatively Promote Hydrogen Peroxide Production, Oxidative DNA Damage, and Upregulation of Dual Oxidase 2 in Human Colon and Pancreatic Cancer Cells
Yongzhong Wu et al.
JOURNAL OF IMMUNOLOGY (2019)
Hypoxia-induced shedding of MICA and HIF1A-mediated immune escape of pancreatic cancer cells from NK cells: role of circ_0000977/miR-153 axis
Zheng-Lin Ou et al.
RNA BIOLOGY (2019)
Strategies in Developing Immunotherapy for Pancreatic Cancer: Recognizing and Correcting Multiple Immune Defects in the Tumor Microenvironment
Sireesha Upadhrasta et al.
JOURNAL OF CLINICAL MEDICINE (2019)
Prognostic and diagnostic significance of galectins in pancreatic cancer: a systematic review and meta-analysis
Qiqing Sun et al.
CANCER CELL INTERNATIONAL (2019)
HH1-1, a novel Galectin-3 inhibitor, exerts anti-pancreatic cancer activity by blocking Galectin-3/EGFR/AKT/FOXO3 signaling pathway
Yanli Yao et al.
CARBOHYDRATE POLYMERS (2019)
Immunogenomic analysis reveals LGALS1 contributes to the immune heterogeneity and immunosuppression in glioma
Qun Chen et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Tumor and endothelial cells collaborate via transcellular receptor complexes
Sarvenaz Sarabipour et al.
JOURNAL OF PATHOLOGY (2019)
Tim-3/galectin-9 pathway and mMDSC control primary and secondary resistances to PD-1 blockade in lung cancer patients
Emeric Limagne et al.
ONCOIMMUNOLOGY (2019)
PODXL1 promotes metastasis of the pancreatic ductal adenocarcinoma by activating the C5aR/C5a axis from the tumor microenvironment
Ken Saito et al.
NEOPLASIA (2019)
Galectin-4 Interaction with CD14 Triggers the Differentiation of Monocytes into Macrophage-like Cells via the MAPK Signaling Pathway
So-Hee Hong et al.
IMMUNE NETWORK (2019)
Transforming growth factor-β modulates pancreatic cancer associated fibroblasts cell shape, stiffness and invasion
Andreas Stylianou et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2018)
Galectins: Multitask signaling molecules linking fibroblast, endothelial and immune cell programs in the tumor microenvironment
Maria T. Elola et al.
CELLULAR IMMUNOLOGY (2018)
Risk of pancreatic cancer associated with family history of cancer and other medical conditions by accounting for smoking among relatives
E. Molina-Montes et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2018)
Role of Galectins in Tumors and in Clinical Immunotherapy
Feng-Cheng Chou et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Galectin Targeted Therapy in Oncology: Current Knowledge and Perspectives
Kamil Wdowiak et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
VEGF receptor-2/neuropilin 1 trans-complex formation between endothelial and tumor cells is an independent predictor of pancreatic cancer survival
Eric Morin et al.
JOURNAL OF PATHOLOGY (2018)
Tumor-associated macrophages promote progression and the Warburg effect via CCL18/NF-kB/VCAM-1 pathway in pancreatic ductal adenocarcinoma
Huilin Ye et al.
CELL DEATH & DISEASE (2018)
Galectins in intestinal inflammation: Galectin-1 expression Delineates response to treatment in celiac Disease Patients
Victoria Sundblad et al.
FRONTIERS IN IMMUNOLOGY (2018)
The role of Galectin-3 in modulating tumor growth and immunosuppression within the tumor microenvironment
Mohammad Farhad et al.
ONCOIMMUNOLOGY (2018)
Pancreatic ductal adenocarcinoma cell secreted extracellular vesicles containing ceramide-1-phosphate promote pancreatic cancer stem cell motility
Norbert Kuc et al.
BIOCHEMICAL PHARMACOLOGY (2018)
Anergic natural killer cells educated by tumor cells are associated with a poor prognosis in patients with advanced pancreatic ductal adenocarcinoma
Chao Yang et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2018)
Nrf2 activation drive macrophages polarization and cancer cell epithelial-mesenchymal transition during interaction
Rui Feng et al.
CELL COMMUNICATION AND SIGNALING (2018)
Cancer-Associated Fibroblasts in Pancreatic Cancer: Should They Be Deleted or Reeducated?
Chao Qu et al.
INTEGRATIVE CANCER THERAPIES (2018)
Role of angiogenesis in pancreatic cancer biology and therapy
Zheng Zhang et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Long-term effects: Galectin-1 and specific immunotherapy for allergic responses in the intestine
L-T Yang et al.
ALLERGY (2018)
TLR4-mediated galectin-1 production triggers epithelial-mesenchymal transition in colon cancer cells through ADAM10-and ADAM17-associated lactate production
Ga Bin Park et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2017)
RN1, a novel galectin-3 inhibitor, inhibits pancreatic cancer cell growth in vitro and in vivo via blocking galectin-3 associated signaling pathways
L. Zhang et al.
ONCOGENE (2017)
Tim-3 and its role in regulating anti-tumor immunity
Madhumita Das et al.
IMMUNOLOGICAL REVIEWS (2017)
Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer
Daniel Ohlund et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2017)
The role of stromal cancer-associated fibroblasts in pancreatic cancer
Dagny von Ahrens et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2017)
Dectin 1 activation on macrophages by galectin 9 promotes pancreatic carcinoma and peritumoral immune tolerance
Donnele Daley et al.
NATURE MEDICINE (2017)
Contribution of galectin-1, a glycan-binding protein, to gastrointestinal tumor progression
Maria L. Bacigalupo et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2017)
Dietary Patterns and Pancreatic Cancer Risk: A Meta-Analysis
Pei-Ying Lu et al.
NUTRIENTS (2017)
Galectin-3 acts as an angiogenic switch to induce tumor angiogenesis via Jagged-1/Notch activation
Sofia Nascimento dos Santos et al.
ONCOTARGET (2017)
Functions of pancreatic stellate cell-derived soluble factors in the microenvironment of pancreatic ductal carcinoma
Qi Wu et al.
ONCOTARGET (2017)
The Presence of Interleukin-13 at Pancreatic ADM/PanIN Lesions Alters Macrophage Populations and Mediates Pancreatic Tumorigenesis
Geou-Yarh Liou et al.
CELL REPORTS (2017)
Potential prognostic biomarkers in pancreatic juice of resectable pancreatic ductal adenocarcinoma
Shefali Agrawal
WORLD JOURNAL OF CLINICAL ONCOLOGY (2017)
Insulin resistance is associated with the aggressiveness of pancreatic ductal carcinoma
Erica Dugnani et al.
ACTA DIABETOLOGICA (2016)
Insulin promotes proliferation and fibrosing responses in activated pancreatic stellate cells
Jiayue Yang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2016)
Inhibition of Galectin-1 Sensitizes HRAS-driven Tumor Growth to Rapamycin Treatment
James V. Michael et al.
ANTICANCER RESEARCH (2016)
Ceramide 1-phosphate regulates cell migration and invasion of human pancreatic cancer cells
Io-Guane Rivera et al.
BIOCHEMICAL PHARMACOLOGY (2016)
The Emerging Hallmarks of Cancer Metabolism
Natalya N. Pavlova et al.
CELL METABOLISM (2016)
Targeting tumor-associated macrophages to combat pancreatic cancer
Ran Cui et al.
ONCOTARGET (2016)
Hypoxia Inducible Factor 1 (HIF-1) Recruits Macrophage to Activate Pancreatic Stellate Cells in Pancreatic Ductal Adenocarcinoma
Na Li et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Galectin-1 Accelerates Wound Healing by Regulating the Neuropilin-1/Smad3/NOX4 Pathway and ROS Production in Myofibroblasts
Yueh-Te Lin et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2015)
G3-C12 Peptide Reverses Galectin-3 from Foe to Friend for Active Targeting Cancer Treatment
Wei Sun et al.
MOLECULAR PHARMACEUTICS (2015)
Apoptosis and anergy of T cell induced by pancreatic stellate cells-derived galectin-1 in pancreatic cancer
Dong Tang et al.
TUMOR BIOLOGY (2015)
Alternatively activated macrophages promote pancreatic fibrosis in chronic pancreatitis
Jing Xue et al.
NATURE COMMUNICATIONS (2015)
Galectin-3 Shapes Antitumor Immune Responses by Suppressing CD8+ T Cells via LAG-3 and Inhibiting Expansion of Plasmacytoid Dendritic Cells
Theodore Kouo et al.
CANCER IMMUNOLOGY RESEARCH (2015)
Elevation of MMP-9 and IDO induced by pancreatic cancer cells mediates natural killer cell dysfunction
Yun-Peng Peng et al.
BMC CANCER (2014)
Natural Killer Cells Eradicate Galectin-1-Deficient Glioma in the Absence of Adaptive Immunity
Gregory J. Baker et al.
CANCER RESEARCH (2014)
Galectin-1 Drives Pancreatic Carcinogenesis through Stroma Remodeling and Hedgehog Signaling Activation
Neus Martinez-Bosch et al.
CANCER RESEARCH (2014)
A Short Treatment with Galactomannan GM-CT-01 Corrects the Functions of Freshly Isolated Human Tumor-Infiltrating Lymphocytes
Nathalie Demotte et al.
CLINICAL CANCER RESEARCH (2014)
OTX008, a selective small-molecule inhibitor of galectin-1, downregulates cancer cell proliferation, invasion and tumour angiogenesis
Lucile Astorgues-Xerri et al.
EUROPEAN JOURNAL OF CANCER (2014)
Galectin-1 links tumor hypoxia and radiotherapy
Peiwen Kuo et al.
GLYCOBIOLOGY (2014)
Galectin-1 and-9 in angiogenesis: A sweet couple
Victor L. Thijssen et al.
GLYCOBIOLOGY (2014)
Intracellular galectins in cancer cells: Potential new targets for therapy ( Review)
Maria C. Vladoiu et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2014)
The role of quantitative mass spectrometry in the discovery of pancreatic cancer biomarkers for translational science
Daniel Ansari et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2014)
Galectin-3 Up-Regulation in Hypoxic and Nutrient Deprived Microenvironments Promotes Cell Survival
Rafael Yamashita Ikemori et al.
PLOS ONE (2014)
Targeting Galectin-1 in pancreatic cancer: immune surveillance on guard
Neus Martinez-Bosch et al.
ONCOIMMUNOLOGY (2014)
Metabolism under hypoxia in Tm1 murine melanoma cells is affected by the presence of galectin-3, a metabolomics approach
Pedro Starzynski Bacchi et al.
SPRINGERPLUS (2014)
Regulation of NKG2D-ligand cell surface expression by intracellular calcium after HDAC-inhibitor treatment
Helle Jensen et al.
MOLECULAR IMMUNOLOGY (2013)
Galectin-9 in Cancer Therapy
Shintaro Fujihara et al.
RECENT PATENTS ON ENDOCRINE METABOLIC & IMMUNE DRUG DISCOVERY (2013)
Altered Sphingolipid Metabolism in Patients with Metastatic Pancreatic Cancer
Yixing Jiang et al.
BIOMOLECULES (2013)
Galectin-1 as a potent target for cancer therapy: role in the tumor microenvironment
Koichi Ito et al.
CANCER AND METASTASIS REVIEWS (2012)
Tim-3/galectin-9 signaling pathway mediates T-cell dysfunction and predicts poor prognosis in patients with hepatitis B virus-associated hepatocellular carcinoma
Hang Li et al.
HEPATOLOGY (2012)
High expression of Galectin-1 in pancreatic stellate cells plays a role in the development and maintenance of an immunosuppressive microenvironment in pancreatic cancer
Dong Tang et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
The expressions and clinical significances of tissue and serum galectin-3 in pancreatic carcinoma
Ling Xie et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2012)
Disrupting galectin-1 interactions with N-glycans suppresses hypoxia-driven angiogenesis and tumorigenesis in Kaposi's sarcoma
Diego O. Croci et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Characterization of proteins secreted by pancreatic cancer cells with anticancer drug treatment in vitro
Takanobu Takata et al.
ONCOLOGY REPORTS (2012)
Overexpressed Galectin-3 in Pancreatic Cancer Induces Cell Proliferation and Invasion by Binding Ras and Activating Ras Signaling
Shumei Song et al.
PLOS ONE (2012)
HOW DOES IT ACT WHEN SOLUBLE? CRITICAL EVALUATION OF MECHANISM OF GALECTIN-1 INDUCED T-CELL APOPTOSIS
Andrea Blasko et al.
ACTA BIOLOGICA HUNGARICA (2011)
Thiodigalactoside inhibits murine cancers by concurrently blocking effects of galectin-1 on immune dysregulation, angiogenesis and protection against oxidative stress
Koichi Ito et al.
ANGIOGENESIS (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Galectin-1 and Galectin-8 Have Redundant Roles in Promoting Plasma Cell Formation
Chih-Ming Tsai et al.
JOURNAL OF IMMUNOLOGY (2011)
Tumor Cells Secrete Galectin-1 to Enhance Endothelial Cell Activity
Victor L. Thijssen et al.
CANCER RESEARCH (2010)
A Galectin-3 Ligand Corrects the Impaired Function of Human CD4 and CD8 Tumor-Infiltrating Lymphocytes and Favors Tumor Rejection in Mice
Nathalie Demotte et al.
CANCER RESEARCH (2010)
Overexpression of Smoothened Activates the Sonic Hedgehog Signaling Pathway in Pancreatic Cancer-Associated Fibroblasts
Kimberly Walter et al.
CLINICAL CANCER RESEARCH (2010)
IL-4 induces cathepsin protease activity in tumor-associated macrophages to promote cancer growth and invasion
Vasilena Gocheva et al.
GENES & DEVELOPMENT (2010)
Mechanism of tumor cell-induced T-cell apoptosis mediated by galectin-1
Ferenc Kovacs-Solyom et al.
IMMUNOLOGY LETTERS (2010)
Role of the JNK/c-Jun/AP-1 signaling pathway in galectin-1-induced T-cell death
B. Brandt et al.
CELL DEATH & DISEASE (2010)
The immunological potential of galectin-1 and-3
Amy Dhirapong et al.
AUTOIMMUNITY REVIEWS (2009)
Increased expression of ALCAM/CD166 in pancreatic cancer is an independent prognostic marker for poor survival and early tumour relapse
C. Kahlert et al.
BRITISH JOURNAL OF CANCER (2009)
CD45-Mediated Fodrin Cleavage during Galectin-1 T Cell Death Promotes Phagocytic Clearance of Dying Cells
Mabel Pang et al.
JOURNAL OF IMMUNOLOGY (2009)
Galectin-3 negatively regulates TCR-mediated CD4+ T-cell activation at the immunological synapse
Huan-Yuan Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Hypoxia stimulates pancreatic stellate cells to induce fibrosis and angiogenesis in pancreatic cancer
Atsushi Masamune et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2008)
CD7 expression and galectin-1-induced apoptosis of immature thymocytes Are directly regulated by NF-κB upon T-cell activation
Han S. Koh et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Sonic Hedgehog Promotes Desmoplasia in Pancreatic Cancer
Jennifer M. Bailey et al.
CLINICAL CANCER RESEARCH (2008)
Galectin-9 Increases Tim-3+ Dendritic Cells and CD8+ T Cells and Enhances Antitumor Immunity via Galectin-9-Tim-3 Interactions
Keiko Nagahara et al.
JOURNAL OF IMMUNOLOGY (2008)
Galectin-3 is a negative regulator of lipopolysaccharide-mediated inflammation
Yubin Li et al.
JOURNAL OF IMMUNOLOGY (2008)
Regulation of alternative macrophage activation by galectin-3
Alison C. MacKinnon et al.
JOURNAL OF IMMUNOLOGY (2008)
A pivotal role for galectin-1 in fetomaternal tolerance
Sandra M. Blois et al.
NATURE MEDICINE (2007)
Stromal biology of pancreatic cancer
Gerald C. Chu et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2007)
Acid sphingomyelinase mediated release of ceramide is essential to trigger the mitochondrial pathway of apoptosis by galectin-1
Gabriela Ion et al.
CELLULAR SIGNALLING (2006)
Aberrant expression of a disintegrin and metalloproteinase 17/tumor necrosis factor-α converting enzyme increases the malignant potential in human pancreatic ductal adenocarcinoma
Joerg Ringel et al.
CANCER RESEARCH (2006)
Galectin-1 suppresses autoimmune retinal disease by promoting concomitant Th2- and T regulatory-mediated anti-inflammatory responses
Marta A. Toscano et al.
JOURNAL OF IMMUNOLOGY (2006)
Galectin-1 induces chemokine production and proliferation in pancreatic stellate cells
A Masamune et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2006)
Galectin-3 and galectin-1 bind distinct cell surface glycoprotein receptors to induce T cell death
BN Stillman et al.
JOURNAL OF IMMUNOLOGY (2006)
Galectin-1 is an inductor of pancreatic stellate cell activation
B Fitzner et al.
CELLULAR SIGNALLING (2005)
Galectin-1 sensitizes resting human T lymphocytes to Fas (CD95)-mediated cell death via mitochondrial hyperpolarization, budding, and fission
P Matarrese et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Galectins as modulators of tumour progression
FT Liu et al.
NATURE REVIEWS CANCER (2005)
Targeted inhibition of galectin-1 gene expression in tumor cells results in heightened T cell-mediated rejection: A potential mechanism of tumor-immune privilege
N Rubinstein et al.
CANCER CELL (2004)
Dimeric galectin-1 induces IL-10 production in T-lymphocytes: an important tool in the regulation of the immune response
J van der Leij et al.
JOURNAL OF PATHOLOGY (2004)
Phylogenetic analysis of the vertebrate galectin family
D Houzelstein et al.
MOLECULAR BIOLOGY AND EVOLUTION (2004)
Inflammatory mechanisms contributing to pancreatic cancer development
B Farrow et al.
ANNALS OF SURGERY (2004)
Critical role of galectin-3 in phagocytosis by macrophages
H Sano et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Expression of T/NK-cell and plasma cell antigens in nonhematopoietic epithelioid neoplasms - An immunohistochemical study of 447 cases
PG Chu et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2003)
Inhibition of human cancer cell growth and metastasis in nude mice by oral intake of modified citrus pectin
P Nangia-Makker et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2002)
Receptor tyrosine phosphatase, CD45 binds galectin-1 but does not mediate its apoptotic signal in T cell lines
R Fajka-Boja et al.
IMMUNOLOGY LETTERS (2002)
Fas (CD95/APO-1) and Fas ligand expression in normal pancreas and pancreatic tumors - Implications for immune privilege and immune escape
WV Bernstorff et al.
CANCER (2002)
Galectin genes: Regulation of expression
L Chiariotti et al.
GLYCOCONJUGATE JOURNAL (2002)
CD45 modulates galectin-1-induced T cell death:: Regulation by expression of core 2 O-glycans
JT Nguyen et al.
JOURNAL OF IMMUNOLOGY (2001)
Hypoxia and oxidative stress in breast cancer - Oxidative stress: its effects on the growth, metastatic potential and response to therapy of breast cancer
NS Brown et al.
BREAST CANCER RESEARCH (2001)
Human galectin-3 is a novel chemoattractant for monocytes and macrophages
H Sano et al.
JOURNAL OF IMMUNOLOGY (2000)
Galectin-3 overexpression protects from cell damage and death by influencing mitochondrial homeostasis
P Matarrese et al.
FEBS LETTERS (2000)
Targeted disruption of the galectin-3 gene results in attenuated peritoneal inflammatory responses
DK Hsu et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
Cutting edge: CD7 delivers a pro-apoptotic signal during galectin-1-induced T cell death
KE Pace et al.
JOURNAL OF IMMUNOLOGY (2000)
Share Paper
